Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alfredo E Rodriguez

Showing results (21-30 of 59) with videos related to

Pageof 6
Sort By:
Panminerva Medica|November 7, 2024
Complete versus culprit-only coronary revascularization in patients with myocardial infarction and multivessel disease undergoing percutaneous coronary intervention: an updated meta-analysisAlfredo M Rodriguez-Granillo, Walter Masson, Martin Lobo, et al.
American Heart Journal|August 10, 2005
Latin American randomized trial of balloon angioplasty versus coronary stenting in diabetic patients with small vessel reference size (Latin American Small Vessel [LASMAL II] Trial): immediate and long-term resultsAlfredo E Rodriguez, Maximo Rodriguez Alemparte, Carlos Fernandez Pereira, et al.
Journal of the American College of Cardiology|August 16, 2005
Five-year follow-up of the Argentine randomized trial of coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple vessel disease (ERACI II)Alfredo E Rodriguez, Julio Baldi, Carlos Fernández Pereira, et al.
Journal of the American College of Cardiology|August 10, 2010
Comparison of AngioJet rheolytic thrombectomy before direct infarct artery stenting with direct stenting alone in patients with acute myocardial infarction. The JETSTENT trialAngela Migliorini, Amerigo Stabile, Alfredo E Rodriguez, et al.
The Annals of Thoracic Surgery|December 26, 2024
Causes of Death After Coronary Revascularization in Patients With DiabetesLucas C Godoy, Valentin Fuster, Louai Razzouk, et al.
European Heart Journal|July 28, 2007
Late loss of early benefit from drug-eluting stents when compared with bare-metal stents and coronary artery bypass surgery: 3 years follow-up of the ERACI III registryAlfredo E Rodriguez, Andrew O Maree, Juan Mieres, et al.
Journal of Cardiovascular Computed Tomography|January 12, 2010
Chronic myocardial infarction detection and characterization during coronary artery calcium scoring acquisitionsGastón A Rodríguez-Granillo, Miguel A Rosales, Paola Renes, et al.
The American Journal of Cardiology|February 18, 2014
Comparison of cost-effectiveness of oral rapamycin plus bare-metal stents versus first generation of drug-eluting stents (from the Randomized Oral Rapamycin in Argentina [ORAR] 3 trial)Alfredo E Rodriguez, Igor Palacios, Alfredo M Rodriguez-Granillo, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 24, 2011
Randomized comparison of cost-saving and effectiveness of oral rapamycin plus bare-metal stents with drug-eluting stents: three-year outcome from the randomized oral rapamycin in Argentina (ORAR) III trialAlfredo E Rodriguez, Alfredo M Rodriguez-Granillo, David Antoniucci, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 17, 2009
Revascularization strategies of coronary multiple vessel disease in the Drug Eluting Stent Era: one year follow-up results of the ERACI III TrialAlfredo E Rodriguez, Liliana Grinfeld, Carlos Fernandez-Pereira, et al.
Pageof 6

Showing results (21-30 of 59) with videos related to

Sort By:
Pageof 6
Panminerva Medica|November 7, 2024
Complete versus culprit-only coronary revascularization in patients with myocardial infarction and multivessel disease undergoing percutaneous coronary intervention: an updated meta-analysisAlfredo M Rodriguez-Granillo, Walter Masson, Martin Lobo, et al.
American Heart Journal|August 10, 2005
Latin American randomized trial of balloon angioplasty versus coronary stenting in diabetic patients with small vessel reference size (Latin American Small Vessel [LASMAL II] Trial): immediate and long-term resultsAlfredo E Rodriguez, Maximo Rodriguez Alemparte, Carlos Fernandez Pereira, et al.
Journal of the American College of Cardiology|August 16, 2005
Five-year follow-up of the Argentine randomized trial of coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple vessel disease (ERACI II)Alfredo E Rodriguez, Julio Baldi, Carlos Fernández Pereira, et al.
Journal of the American College of Cardiology|August 10, 2010
Comparison of AngioJet rheolytic thrombectomy before direct infarct artery stenting with direct stenting alone in patients with acute myocardial infarction. The JETSTENT trialAngela Migliorini, Amerigo Stabile, Alfredo E Rodriguez, et al.
The Annals of Thoracic Surgery|December 26, 2024
Causes of Death After Coronary Revascularization in Patients With DiabetesLucas C Godoy, Valentin Fuster, Louai Razzouk, et al.
European Heart Journal|July 28, 2007
Late loss of early benefit from drug-eluting stents when compared with bare-metal stents and coronary artery bypass surgery: 3 years follow-up of the ERACI III registryAlfredo E Rodriguez, Andrew O Maree, Juan Mieres, et al.
Journal of Cardiovascular Computed Tomography|January 12, 2010
Chronic myocardial infarction detection and characterization during coronary artery calcium scoring acquisitionsGastón A Rodríguez-Granillo, Miguel A Rosales, Paola Renes, et al.
The American Journal of Cardiology|February 18, 2014
Comparison of cost-effectiveness of oral rapamycin plus bare-metal stents versus first generation of drug-eluting stents (from the Randomized Oral Rapamycin in Argentina [ORAR] 3 trial)Alfredo E Rodriguez, Igor Palacios, Alfredo M Rodriguez-Granillo, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|November 24, 2011
Randomized comparison of cost-saving and effectiveness of oral rapamycin plus bare-metal stents with drug-eluting stents: three-year outcome from the randomized oral rapamycin in Argentina (ORAR) III trialAlfredo E Rodriguez, Alfredo M Rodriguez-Granillo, David Antoniucci, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 17, 2009
Revascularization strategies of coronary multiple vessel disease in the Drug Eluting Stent Era: one year follow-up results of the ERACI III TrialAlfredo E Rodriguez, Liliana Grinfeld, Carlos Fernandez-Pereira, et al.
Pageof 6